A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
- 16 September 2022
- journal article
- research article
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 187,p. e64123
Abstract
The term liquid biopsy (LB) refers to molecules such as proteins, DNA, RNA, cells, or extracellular vesicles in blood and other bodily fluids that originate from the primary and/or metastatic tumor. LB has emerged as a mainstay in translational research and has started to become part of clinical oncology practice, providing a minimally invasive alternative to solid biopsy. The LB allows real-time monitoring of a tumor via a minimally invasive sample extraction, such as blood. The applications include early cancer detection, patient follow-up for the detection of disease progression, assessment of minimal residual disease, and potential identification of molecular progression and mechanism of resistance. In order to achieve a reliable analysis of these samples that can be reported in the clinic, the preanalytical procedures should be carefully considered and strictly followed. Sample collection, quality, and storage are crucial steps that determine their usefulness in downstream applications. Here, we present standardized protocols from our liquid biopsy working module for collecting, processing, and storing plasma and serum samples for downstream liquid biopsy analysis based on circulating-free DNA. The protocols presented here require standard equipment and are sufficiently flexible to be applied in most laboratories focused on biological procedures.Keywords
This publication has 19 references indexed in Scilit:
- Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancerESMO Open, 2022
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAnnals of Oncology, 2021
- How to use liquid biopsies to treat patients with cancerESMO Open, 2021
- Liquid biopsy enters the clinic — implementation issues and future challengesNature Reviews Clinical Oncology, 2021
- Application of exosomes as liquid biopsy in clinical diagnosisSignal Transduction and Targeted Therapy, 2020
- Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public DatabasesClinical Pharmacology & Therapeutics, 2020
- Considerations and quality controls when analyzing cell-free tumor DNABiomolecular Detection and Quantification, 2019
- Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literatureHeliyon, 2018
- Inhibition mechanisms of hemoglobin, immunoglobulin G, and whole blood in digital and real-time PCRAnalytical and Bioanalytical Chemistry, 2018
- Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung diseaseBritish Journal of Cancer, 2015